These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20300788)

  • 1. Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia.
    Stamnaes J; Dorum S; Fleckenstein B; Aeschlimann D; Sollid LM
    Amino Acids; 2010 Nov; 39(5):1183-91. PubMed ID: 20300788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TG6 Auto-Antibodies in Dermatitis Herpetiformis.
    Hadjivassiliou M; Reunala T; Hervonen K; Aeschlimann P; Aeschlimann D
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
    Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
    Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
    Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
    Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
    Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.
    Hadjivassiliou M; Aeschlimann P; Sanders DS; Mäki M; Kaukinen K; Grünewald RA; Bandmann O; Woodroofe N; Haddock G; Aeschlimann DP
    Neurology; 2013 May; 80(19):1740-5. PubMed ID: 23576621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease.
    Kaunisto H; Salmi T; Lindfors K; Kemppainen E
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut.
    Hietikko M; Hervonen K; Ilus T; Salmi T; Huhtala H; Laurila K; Rauhavirta T; Reunala T; Kaukinen K; Lindfors K
    Acta Derm Venereol; 2018 Mar; 98(3):366-372. PubMed ID: 29182792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.
    Gadoth A; Nefussy B; Bleiberg M; Klein T; Artman I; Drory VE
    JAMA Neurol; 2015 Jun; 72(6):676-81. PubMed ID: 25867286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis.
    Caproni M; Capone M; Rossi MC; Santarlasci V; Maggi L; Mazzoni A; Rossettini B; Renzi D; Quintarelli L; Bianchi B; Ninci A; Lami G; Calabrò A; Cosmi L; Annunziato F; Liotta F
    Front Immunol; 2021; 12():645143. PubMed ID: 33959126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.
    Kemppainen E; Salmi T; Lindfors K
    Front Immunol; 2021; 12():657280. PubMed ID: 33854513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatitis herpetiformis].
    Juratli HA; Görög A; Sárdy M
    Hautarzt; 2019 Apr; 70(4):260-264. PubMed ID: 30868254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation.
    Kárpáti S; Sárdy M; Németh K; Mayer B; Smyth N; Paulsson M; Traupe H
    Exp Dermatol; 2018 Aug; 27(8):807-814. PubMed ID: 28940785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis.
    Das S; Stamnaes J; Kemppainen E; Hervonen K; Lundin KEA; Parmar N; Jahnsen FL; Jahnsen J; Lindfors K; Salmi T; Iversen R; Sollid LM
    Adv Sci (Weinh); 2023 Sep; 10(25):e2300401. PubMed ID: 37424036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatitis herpetiformis.
    Kárpáti S
    Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody binding and unique enzyme-substrate intermediate conformation of human transglutaminase 3.
    Heggelund JE; Das S; Stamnaes J; Iversen R; Sollid LM
    Nat Commun; 2023 Oct; 14(1):6216. PubMed ID: 37798283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.